HuGE Literature Finder
Records
1
-
2
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science translational medicine 2020 Feb 12 (531): . Coussy Florence, El-Botty Rania, Château-Joubert Sophie, Dahmani Ahmed, Montaudon Elodie, Leboucher Sophie, Morisset Ludivine, Painsec Pierre, Sourd Laura, Huguet Léa, Nemati Fariba, Servely Jean-Luc, Larcher Thibaut, Vacher Sophie, Briaux Adrien, Reyes Cécile, La Rosa Philippe, Lucotte Georges, Popova Tatiana, Foidart Pierre, Sounni Nor Eddine, Noel Agnès, Decaudin Didier, Fuhrmann Laetitia, Salomon Anne, Reyal Fabien, Mueller Christopher, Ter Brugge Petra, Jonkers Jos, Poupon Marie-France, Stern Marc-Henri, Bièche Ivan, Pommier Yves, Marangoni Elisabet |
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 17, 2022
- Content source: